spironolactone group:spironolactone

2 trials

Sponsors

Drum Tower Hospital Affiliated to Nanjing University Medical School, Army Medical Center of PLA

Conditions

Primary Aldosteronismhypertension

Phase 4

Compare the Efficacy and Safety of Finerenone, a New Type of Mineralocorticoid Receptor Antagonist, and Spironolactone in the Treatment of Primary Aldosteronism: a Single-Center, Prospective, Randomized Controlled Study

Active, not recruitingChiCTR2300069660

Drum Tower Hospital Affiliated to Nanjing University Medical SchoolPrimary Aldosteronism

Start: 2023-04-01Updated: 2023-05-29

Unknown Phase

A multicenter randomized controlled intervention study on bilateral adrenal artery ablation for the treatment of idiopathic aldosteronism

Active, not recruitingChiCTR2400092478

Army Medical Center of PLAhypertension

Start: 2024-11-20Updated: 2024-12-02